RxDoctor Payments DataLook up a doctor →

Michael Rua, PA

Medical · Smithfield, PANPI 1851321574

Payments from drug & device makers

$17,877in general payments, 2019–2025

Across 1,179 payments — averaging $15.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AstraZeneca$2K
  • AbbVie$2K
  • Lilly USA, LLC$2K
  • Boehringer Ingelheim$1K
  • GSK$1K
  • plus $8K from 49 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk152$2,210
AstraZeneca63$1,648
AbbVie(2 entities)133$1,640
Lilly USA, LLC112$1,586
Boehringer Ingelheim112$1,398
GSK96$1,287
Pfizer97$1,229
Amgen38$652
Bayer41$646
Amarin Pharma, Inc.30$515
Johnson & Johnson36$470
Sanofi-aventis U.S. LLC23$273
Exact Sciences13$270
Shield Therapeutics Inc7$269
Averitas Pharma Inc.13$269
Biohaven Pharmaceutical Holding Company Ltd.17$254
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC14$215
Takeda Pharmaceuticals U.S.A., Inc.14$209
Biohaven Pharmaceuticals, Inc.11$206
Sunovion Pharmaceuticals Inc.16$195
Idorsia Pharmaceuticals US Inc12$194
Azurity Pharmaceuticals, Inc.10$172
Ironwood Pharmaceuticals, Inc10$165
Merck7$138
Daiichi Sankyo Inc.5$131
Abbott7$120
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)6$104
Astellas Pharma US Inc6$102
Medtronic5$101
E.r. Squibb & Sons, L.L.C.3$99
Arbor Pharmaceuticals, Inc.6$94
Dexcom, Inc.6$93
Otsuka America Pharmaceutical, Inc.6$91
Esperion Therapeutics, Inc.6$90
Novartis5$88
Phathom Pharmaceuticals, Inc.5$69
Eisai Inc.5$67
Ultragenyx Pharmaceutical Inc.4$58
Hikma Pharmaceuticals USA4$55
Axsome Therapeutics, Inc.2$40
Sanofi Pasteur Inc.2$38
Teva Pharmaceuticals USA, Inc.2$36
Insulet Corporation2$32
Redhill Biopharma Inc.2$31
Inspire Medical Systems, Inc.1$29
Currax Pharmaceuticals LLC2$28
Cequr Corporation1$26
Avanir Pharmaceuticals, Inc.2$25
Medicure Pharma Inc.1$24
Xeris Pharmaceuticals, Inc.1$21
Grifols USA, LLC1$18
Eyevance Pharmaceuticals LLC1$16
Pacira Pharmaceuticals Incorporated1$15
Lundbeck LLC1$14
Bioventus LLC1$12

How this compares

$17,877 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$53,494
Medicare patients
136
Services billed
761

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Smithfield

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →